MedPath

A study of diffuse hair loss in males & comparision of treatment modalities like PRP with minoxidil & finasteride

Not yet recruiting
Conditions
Androgenic alopecia, unspecified,
Registration Number
CTRI/2023/04/051903
Lead Sponsor
Santosh medical college and hospital
Brief Summary

Androgenetic alopecia  is a hereditary autosomal dominant, androgen- dependent disorder characterized by progressive, patterned hair loss from the scalp, and occurs in both men and women. Various treatment modalities have been tried. Combination of topical minoxidil and finasteride have shown some success. Recently, Platelet rich plasma which contains concentrated platelet and other growth factors have been used as adjuvant therapy. Because of paucity of literature of comparing various topical modalities prompted us to undertake the study to compare PRP combined with minoxidil and finasteride, PRP alone, minoxidil and finasteride topical solution alone and control.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
Male
Target Recruitment
80
Inclusion Criteria

Patients within age group of 18-50 year, not using topical minoxidil and oral or topical finasteride for atleast 6 months, willing to come for regular follow up, platelet count> 1.5 lacs per microlitre of blood.

Exclusion Criteria

Uncooperstive patients, any dermatological disease of scalp, tendency to form keloid, patient is on anticoagulant therapy.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To find effectiveness of PRPat end of 6 months
Secondary Outcome Measures
NameTimeMethod
To compare between efficacy of PRP with minoxidil and finasteride solutionat end of 6 months

Trial Locations

Locations (1)

santosh hospital

🇮🇳

Ghaziabad, UTTAR PRADESH, India

santosh hospital
🇮🇳Ghaziabad, UTTAR PRADESH, India
Dr VK Garg
Principal investigator
9968604367
vijaykga@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.